Integer to Participate at Upcoming Investor Conferences

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the medical device contract development and manufacturing sector, has announced its participation in two significant investor conferences scheduled for December. The executive leadership team will represent the company at the Piper Sandler 37th Annual Healthcare Conference on December 2 at 8:00 a.m. ET, followed by the Citi’s 2025 Global Healthcare Conference on December 3 at 9:45 a.m. ET.

Investors and interested parties will have the opportunity to access live webcasts and replays of both events, which will be available under the “News & Events” section on Integer's Investor Relations website at investor.integer.net. These conferences provide a platform for Integer to communicate its growth strategies and innovations, reinforcing its position in the healthcare sector.

Integer is recognized as one of the largest medical device contract development and manufacturing organizations globally, specializing in markets such as cardiac rhythm management, neuromodulation, and cardiovascular solutions. The company operates under well-known brands, including Greatbatch Medical® and Lake Region Medical®. Its commitment to improving patient outcomes through high-quality, innovative medical products is central to its mission.

For further information on Integer and to stay updated on their initiatives, stakeholders can visit their official website at www.integer.net. For inquiries, investors and media can reach out to Kristen Stewart for investor relations at 551.337.3973 or kristen.stewart@integer.net, and Lauren Ban for media relations at 469.476.9615 or lauren.ban@integer.net. As Integer prepares for these vital investor engagements, it underscores the company’s dedication to transparency and stakeholder communication in the evolving healthcare landscape.

Integer Holdings Corporation (NYSE: ITGR) is set to participate in key investor conferences in December, namely the Piper Sandler 37th Annual Healthcare Conference and Citi's 2025 Global Healthcare Conference. As a leading player in the contract development and manufacturing organization (CDMO) space for medical devices, Integer's attendance at these events presents a strategic opportunity for investors to evaluate its market positioning and future growth prospects.

Given the increasing demand for innovative medical devices, particularly in cardiac rhythm management, neuromodulation, and vascular markets, Integer stands at the forefront of industry advancements. The upcoming conferences will likely be an excellent platform for the company to provide insights into its operational strategies, recent developments, and market outlook, especially following its commitment to enhancing patient lives through high-quality products.

Investors should pay attention to the themes and discussions presented at these conferences. Key management discussions could reveal Integer's responses to market pressures, competitive advantages, and potential partnerships—critical factors that could impact shareholder value.

The live webcasts available on the Integer Investor Relations website will also allow investors who cannot attend to engage with the content and gather relevant information for their investment decisions.

In the current climate, characterized by heightened focus on healthcare innovations amidst regulatory changes and supply chain dynamics, Integer's proven track record and established brands, like Greatbatch Medical and Lake Region Medical, could insulate it from volatility while presenting growth opportunities.

Overall, prospective and current investors should consider both the immediate insights from these conferences and the long-term potential of Integer within the evolving medical device landscape. This engagement will provide a comprehensive understanding that can inform investment strategies over the upcoming quarters.